522.1451—Moxidectin for suspension.
(a) Specifications.
The drug product consists of two separate vials. One contains 10 percent moxidectin microspheres, and the other contains a vehicle for constitution of the moxidectin microspheres. Each milliliter of constituted, sustained-release suspension contains 3.4 milligrams (mg) of moxidectin.
(d) Conditions of use; dogs—
(1) Amount.
0.17 mg per kilogram body weight (0.0773 mg per pound) as a single subcutaneous injection.
(2) Indications for use.
For prevention of heartworm disease caused by Dirofilaria immitis; for treatment of existing larval and adult hookworm (Ancylostoma caninum) and Uncinaria stenocephala infections.
(3) Limitations.
Federal law restricts this drug to use by or on the order of a licensed veterinarian.